MacroGenics
MGNX
#8333
Rank
S$0.33 B
Marketcap
S$5.26
Share price
3.54%
Change (1 day)
173.56%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): S-$0.09250

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$0.06412. In 2024 the company made an earnings per share (EPS) of S-$1.37 a decrease over its 2023 EPS that were of S-$0.19.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.09250-93.26%
2024S-$1.37613.33%
2023S-$0.19-92.31%
2022S-$2.50-42.14%
2021S-$4.3236.44%
2020S-$3.17-21.84%
2019S-$4.05-24.58%
2018S-$5.37675.93%
2017S-$0.69-68.05%
2016S-$2.17168.25%
2015S-$0.81-55%
2014S-$1.803400%
2013S-$0.05130-108.68%
2012S$0.5924.49%
2011S$0.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.68-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.20-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.57-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$8.78-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.56-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.57-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S-$2.27 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA